Submitted by biblioteca unifenas (biblioteca@unifenas.br) on 2018-03-05T22:12:22Z No. of bitstreams: 1 Sávio Carneiro Martins Dissertacao.pdf: 1917056 bytes, checksum: 1e6b06de6f8c419963c162ad0230fffa (MD5) / Made available in DSpace on 2018-03-05T22:12:22Z (GMT). No. of bitstreams: 1 Sávio Carneiro Martins Dissertacao.pdf: 1917056 bytes, checksum: 1e6b06de6f8c419963c162ad0230fffa (MD5) Previous issue date: 2015-03-30 / Due to the importance of in vitro embryo production (IVEP) to accelerate genetic improvement is important the search for technological innovation that can enhance the in vitro embryo development. Mouse embryonic fibroblasts (MEFs) have been widely used as a feeder layer to support embryonic stem cells due to their release of growth factors. Mesenchymal stem cells (MSCs) from different sources were also found to release bioactive factors that can support cell growth. This study aims to investigate the effect of co-culture of MSC from rat bone marrow or MEF as a feeder source for in vitro production of bovine embryos. Cumulus oophorus complexes were matured into three groups: control (CTRL), co-culture with monolayer of mesenchymal cells of rats (MSC) or co-cultured with monolayer of embryonic fibroblasts of mice (MEF). Fertilization was performed in control condition for all groups, and in vitro fertilized embryos were cultured from fourth day on in CTRL, co-culture with MSC or co-cultured with MEF, so that the following groups were performed: (CTRL / CTRL) - maturation and embryo development in CTRL conditions; (CTRL / MSC) - maturation in CTRL and embryo development with MSC from the fourth day on after the beginning of the in vitro embryo culture; (CTRL / MEF) - maturation CTRL and embryo development with MEF from the fourth day on after the beginning of the in vitro embryo culture; (MSC / CTRL) - MSC during maturation and embryo development in CTRL; (MSC / MSC) - maturation and embryo development in MSC from the fourth day on after the beginning of the in vitro embryo culture; (MEF / CTRL) - maturation and embryo development in MEF and CTRL (MEF / MEF) - maturation and embryo development in MEF from the fourth day on after the beginning of embryo development in vitro. No significant difference was found among the oocytes matured in CTRL, MSC and MEF conditions for metaphase II and apoptosis rates and for cleavage rate in embryos at 4th day after the beginning of the in vitro culture. The number of cells in the inner cell mass, trophoblast cells, apoptotic cells and total cells were similar (P> 0.05) in the embryos from all experimental groups. The rates of blastocyst formation, expanded, hatched and the total of blastocysts did not differ among experimental groups (P> 0.05) at 7th day of embryo development. At eighth day of embryo culture we observed a difference (P <0.05) in hatched blastocyst rate which was higher in the CTRL /CTRL group when compared to MSC/MSC group, however, the proportion of blastocyst, expanded and total blastocysts was not different (P> 0.05). We conclude that there was no significant improvement in bovine embryo development using co-cultures of MSC from rats or MEF when compared to control culture system. However more studies investigating the use of stem cells from other sources or their conditioned medium are needed to better understand the effect of these cells on embryonic development. / Diante da importância da produção in vitro de embriões (PIVE) na expansão do melhoramento genético, é importante a busca de inovações tecnológicas que possam potencializar o desenvolvimento embrionário in vitro. Fibroblastos embrionários de camundongo (MEFs) têm sido amplamente utilizados como camada alimentadora para suportar as células-tronco embrionárias, devido à sua liberação de fatores de crescimento. As células-tronco mesenquimais (MSCs) identificadas a partir de diferentes fontes, também liberam fatores bioativos que possam suportar o crescimento celular. Este estudo tem como objetivo investigar o efeito da co-cultura de MSC de medula óssea de rato ou MEF como fonte alimentadora na produção in vitro de embriões bovinos. Complexo cumulus oophorus foram maturados em três grupos distintos: Controle (CTRL), co-cultura com monocamada de células mesenquimais de ratos (MSC) ou co-cultura com monocamada de fibroblastos embrionários de camundongos (MEF). A fecundação foi realizada em condição controle para todos os grupos e os embriões fecundados in vitro foram também cultivados a partir do quarto dia em CTRL, co-cultura com MSC ou co-cultura com MEF, formando os seguintes grupos experimentais: (CTRL/CTRL) – maturação e cultivo embrionário em condições CTRL; (CTRL/MSC) – maturação em CTRL e cultivo embrionário em MSC a partir do quarto dia após o início do cultivo embrionário in vitro; (CTRL/MEF) – maturação em CTRL e cultivo embrionário em MEF a partir do quarto dia após o início do cultivo embrionário in vitro; (MSC/CTRL) – maturação em MSC e cultivo embrionário em CTRL; (MSC/MSC) – maturação e cultivo embrionário em MSC a partir do quarto dia após o início do cultivo embrionário in vitro; (MEF/CTRL) – maturação em MEF e cultivo embrionário em CTRL e (MEF/MEF) – maturação e cultivo embrionário em MEF a partir do quarto dia após o início do cultivo embrionário in vitro. Nenhuma diferença significativa foi encontrada entre os oócitos dos grupos CTRL, MSC e MEF, na taxa de estruturas em metáfase II, apoptose e clivagem nos embriões de 4 dias após o início do cultivo in vitro. O número de células da massa celular interna, células do trofoblasto, células em apoptose e células totais foram iguais (P>0,05) entre os embriões dos diferentes grupos experimentais. As taxas de embriões em estágio de blastocisto, blastocisto expandido, blastocisto eclodido e blastocistos totais dos grupos experimentais não se diferiram (P>0,05) no sétimo dia de cultivo embrionário. No oitavo dia de cultivo embrionário houve diferença (P<0,05) da taxa de blastocisto eclodido, sendo maior no grupo CTRL/CTRL quando comparado ao grupo MSC/MSC; no entanto, a proporção de blastocisto, blastocisto expandido e blastocistos totais não foram diferentes (P>0,05) entre os grupos experimentais. Concluímos que não houve melhora significativa no desenvolvimento embrionário bovino utilizando co-culturas com MSC de ratos ou MEF de camundongos, quando comparado com sistema de cultura controle. Entretanto, mais estudos investigando o uso de células-tronco de outras fontes ou seu meio condicionado são necessários para se entender melhor o efeito destas células no desenvolvimento embrionário.

Submitted by Nadir Basilio (nadirsb@uninove.br) on 2015-07-20T17:06:31Z No. of bitstreams: 1 Vanessa Roza da Silva.pdf: 5985934 bytes, checksum: dd323ab2c936afdeb390f59867f9eab4 (MD5) / Made available in DSpace on 2015-07-20T17:06:31Z (GMT). No. of bitstreams: 1 Vanessa Roza da Silva.pdf: 5985934 bytes, checksum: dd323ab2c936afdeb390f59867f9eab4 (MD5) Previous issue date: 2013-12-19 / Currently the Chronic Obstructive Pulmonary Disease (COPD) has a high prevalence and a high economic and social cost. In this context, several experimental models have been proposed, aiming at the discovery of new therapeutic approaches. Accordingly, the use of mesenchymal stem cells (MSC) is an innovative and accessible treatment of pulmonary acute and chronic disease, as they have important therapeutic potentials (immunoregulation, anti-fibrogenic, inducing proliferation of tissue progenitor cells, anti-apoptotic and pro-angiogenic and chemoattraction). Therapy with low levellaser (LLL) is a relatively new effective therapy, with very low cost and no side effects. In this project we aim to study some parameters in animals with COPD undergoing therapies with LLL (15 days before the experiment) and MSC obtained from human fallopian tube (administered 2 times: 15 days and 7 days before the experiment). The protocol used for the induction of COPD consists in submitting C57BL/6 mice for 75 days (2 times / day) to inhaled cigarette smoke. On day 76ththe animals were sacrified and structural and functional parameters of lungs were evaluated. Our results indicate that the treatment with LLL and MSC greatly reduces lung inflammation (as demonstrated through BAL cell counting and histomorphometric analysis in lung parenchyma), BAL pro-inflammatory cytokines (IL-1β, IL-6, IL-10, TNF-α and KC) and the lung expression of NF-B, NFAT and IL-10. Furthermore, these therapies also reduced airway mucus secretion and collagen deposition. / Atualmente a Doença Pulmonar Obstrutiva Crônica (DPOC) apresenta alta prevalência e um elevado custo econômico e social. Neste contexto, vários modelos experimentais têm sido propostos, objetivando o descobrimento de novas opções terapêuticas. Neste sentido, o uso de células-tronco mesenquimais (CTM) constitui uma estratégia inovadora e acessível para tratamento de doenças pulmonares de caráter agudo e crônico. Essas células-troncos possuem um importante potencial terapêutico (imunorregulação, anti-fibrogênica, indutora da proliferação de células progenitoras teciduais, anti-apoptótica, pró-angiogênica e de quimioatração). A terapia com Laser de Baixa Potência (LBP) é uma terapia relativamente nova e eficaz, de baixíssimo custo, sem efeitos colaterais e de possível utilização no tratamento das doenças crônicas pulmonares. No presente estudo visamos estudar alguns parâmetros em animais com DPOC submetidos às terapias com laser de diodo (660nm), 30 mW, 60 s por ponto (3 pontos por aplicação) por 15 dias antes do experimento e com CTMs obtidas da tuba uterina humana (104 células administradas i.p. ou i.n. 2 vezes: 15 dias e 7 dias antes do experimento).O protocolo utilizado para a indução da DPOC consistiu em nebulizar camundongos fêmeas C57BL/6 com fumaça de cigarro por 75 dias (2 vezes/dia). No dia 76, os animais foram sacrificados e avaliados os parâmetros funcionais e estruturais pulmonares.Nossos resultados indicam que os tratamentos com CTM e LBP reduziram a inflamação pulmonar (demonstrado pela contagem total e diferencial de células do lavadobroncoalveolar (LBA) e análise histomorfométrica do parênquima pulmonar), os níveis de citocinas quimiocinas (IL-1β, IL-6, IL-10, IFN-, TNF-α e, KC) e a expressão de NF-B, NFAT e IL-10 no pulmão. Além disso, essas terapias também reduziram a secreção de muco e deposição de colágeno nas vias aéreas.

As células estromais mesenquimais (CMMs) se tornaram de grande interesse para a terapia celular devido ao seu potencial de se diferenciar e reconstituir tecidos especializados. Mais recentemente, este interesse tem aumentado significativamente devido à descoberta de que as CMMs são capazes de secretar uma infinidade de mediadores para estimular a regeneração in situ de tecidos lesados. Dessa forma, CMMs podem ser consideradas tanto como um produto terapêutico em si, quanto uma biofábrica de diversas proteínas relevantes do ponto de vista terapêutico. Para atender a estas crescentes demandas, ambas as aplicações requerem o desenvolvimento de processos de expansão celular com alto rendimento, sob condições de cultivo definidas, reprodutíveis, escalonáveis, permitindo a obtenção de produtos com adequada identidade, potência, pureza, segurança e viáveis economicamente. Frente ao exposto, este trabalho teve como objetivos principais o estabelecimento de um processo de expansão de CMMs baseado em biorreatores e a caracterização do secretoma destas células visando aplicações terapêuticas. Para isto, a expansão de CMMs do cordão umbilical (MCUs) foi realizada em frascos multicamadas (MC) e nos biorreatores de leito fixo (LF), tanque agitado com microcarregadores (TA) e fibrasocas (FO). Os resultados mostraram que a taxa de proliferação específica das células foi maior (< tempo de duplicação) no biorreator de FO (36,8 ± 1,7 horas), bem como o fator de expansão (9,8 ± 1,0) e a eficiência na recuperação celular (100%). Um nível similar de produção celular foi observado para o TA, MC e LF com elevado fator de expansão celular (8,8 ± 0,39, 8,7 ± 0,90, 6,9 ± 1,3, respectivamente). No entanto, em termos de eficiência na recuperação celular (%), LF apresentou a menor taxa de recuperação dentre todos os sistemas (18% (± 0,77)), acompanhado pelo TA (61% (± 15,7)). As células mantiveram suas características imunofenotípicas e o potencial de diferenciação em adipócitos, osteócitos e condrócitos em todos os sistemas de cultivo avaliados. Foi também realizada a análise de custos (COG) e avaliação da viabilidade econômica para produção de CMMs visando tratamento da doença do enxerto contra o hospedeiro (DECH) em escala comercial, utilizando os sistemas de cultivo avaliados experimentalmente sob diferentes estratégias de reembolso. Apesar dos resultados experimentais satisfatórios para o biorreator FO, o COG revelou que este sistema tem o maior custo devido aos elevados custos dos consumíveis requeridos e do custo do equipamento. O frasco MC foi considerado como a tecnologia mais rentável e robusta no cenário avaliado e o biorreator TA obteve a segunda posição. O biorreator TA foi escolhido como o mais adequado analisando de maneira conjunta os dados experimentais obtidos, a análise dos custos dos diferentes sistemas de cultivo e a escalonabilidade de cada sistema. Assim, esse biorreator foi eficientemente utilizado para o cultivo de MCUs em condições isentas de SFB e xenoantígenos, sendo possível a produção de uma grande quantidade de células, representando um passo importante no desenvolvimento de um bioprocesso em conformidade com as normas das agências regulatórias. Por fim, com a análise do secretoma das CMMs por espectrometria de massas foi possível a identificação de uma gama enorme de proteínas interessantes (aprox. 2400) envolvidas em importantes processos biológicos. O futuro monitoramento dessas proteínas em biorreatores poderá representar um método inovador e original de produção de produtos livres de células para uso na terapia celular. / Mesenchymal stem/stromal cells (MSC) have become of great interest for cell therapy because of its potential to differentiate and reconstitute specialized tissues. More recently, such interest has significantly increased due to the discovery that MSC are capable of secreting a plethora of mediators to stimulate the in situ regeneration of injured tissues. Thus, MSC can be considered as a therapeutic product itself and as a biofactory of various relevant therapeutic proteins. To meet these increasing demands, both applications require the development of high-yield, reproducible, scalable and cost-effective bioprocesses under defined culture conditions, obtaining products with proper identity, purity and safety. Based on these, the main goal of this work was the establishment of a MSC expansion process based on bioreactors and secretome characterization of these cells targeting therapeutic applications. The MSC expansion was performed using multi-layered flasks (ML) and fixed bed (PB), stirred tank (STR) and hollow fiber (HF) bioreactors. The results showed that the proliferation rate of the cells was higher (< doubling time) in the HF bioreactor (36.8 ± 1.7 hours), as well as the expansion fold-increase (9.8±1.0) and harvesting efficiency (100%). A similar level of cell production was observed for STR, ML and PB with high fold-increase (8.8±0.39, 8.7±0.90, 6.9±1.3, respectively). However, in terms of harvesting efficiency (%), PB bioreactor presented the lowest retrieval rate across all the technologies (18% (±0.77)), followed by STR (61% (±15.7)). The cells retained their functional properties after culture in all the culture systems evaluated. This study was then extended through the use of a bioprocess economics tool for the evaluation of the economic feasibility of producing MSC-based treatment for acute graft vs. host disease (aGvHD) at commercial scale, using the culture systems experimentally evaluated under different reimbursement strategies. Despite the advantageous experimental results of HF bioreactors, the COG analysis has revealed that this is the least cost effective cell culture system to be used, due to its high consumable and equipment costs. ML flasks ranked first as the most cost effective and robust technology in this scenario and microcarrier-based technologies (STR) ranked in second position. The STR bioreactor was chosen as the most suitable for MSC expansion analyzing the experimental data, COG analysis and scalability of each culture system. Thus, STR bioreactor was efficiently tested for MSC expansion under serum and xeno-free conditions and it was possible to produce a large amount of cells. The development of a scalable microcarrier-based stirred culture system using xeno-free culture medium that suits the intrinsic features of UCM-derived MSC represents an important step towards a GMP compliant large-scale production platform for these promising cell therapy candidates. Finally, with the MSC secretome analysis by mass spectrometry it was possible to identify a wide range of interesting proteins (approx. 2400) involved in important biological processes. The future monitoring of these proteins in bioreactors may represent a novel and unique method of producing cell-free products for use in cellular therapy.

Bone marrow mesenchymal stromal cells (BM MSCs) represent a heterogeneous population of progenitors with potential for generation of skeletal tissues. However the identity of BM MSC subpopulations is poorly defined mainly due to the absence of specific markers allowing in situ localization of those cells and isolation of pure cell types. Here, we aimed at characterization of surface markers in mouse BM MSCs and in their subsets with distinct differentiation potential. Using conditionally immortalized BM MSCs we performed a screening with 176 antibodies and high-throughput flow cytometry, and found 33 markers expressed in MSCs, and among them 3 were novel for MSCs and 13 have not been reported for MSCs from mice. Furthermore, we obtained clonally derived MSC subpopulations and identified bipotential progenitors capable for osteo- and adipogenic differentiation, as well as monopotential osteogenic and adipogenic clones, and thus confirmed heterogeneity of MSCs. We found that expression of CD200 was characteristic for the clones with osteogenic potential, whereas SSEA4 marked adipogenic progenitors lacking osteogenic capacity, and CD140a was expressed in adipogenic cells independently of their efficiency for osteogenesis. We confirmed our observations in cell sorting experiments and further investigated the expression of those markers during the course of differentiation. Thus, our findings provide to our knowledge the most comprehensive characterization of surface antigens expression in mouse BM MSCs to date, and suggest CD200, SSEA4 and CD140a as markers differentially expressed in distinct types of MSC progenitors.

The purpose of this Master thesis is to verify migration of mesenchymal stem cells on the principle known as chemotaxis. First part of this study is focused on cell migration in order to explain the whole migration process. Next part describes various chemotaxis methods and selected studies dealing with clinical applications of mesenchymal stem cells in different medical and biomedical fields. The following step describes confocal microscopy, which is used for acquiring images of the cells. The experimental part is focused on cultivation of mesenchymal stem cells in a laboratory, which is necessary for cell vitality. Furthermore, there are designed two main experiments. Firstly there is a 2D experiment with adherent cells for chemotaxis using -Slide Chemotaxis. Secondly Transwell migration test is designed and executed. Finally, the acquired images from confocal microscope are used for image processing, which was done in Matlab R2020a programming environment. The result of this processing is evaluation of cell confluence and migration. In the end, experimental part of this study was optimized according to recommended studies. The results are summarized in the conclusion with proposal for improvements of those methods.

Bien que les résultats métaboliques de la transplantation d’îlots chez le patient diabétique de type 1 soient désormais bien démontrés, ils sont contrebalancés par les effets indésirables des traitements immunosuppresseurs et la perte de fonctionnalité du greffon à long terme.Au cours de cette thèse, nous avons étudié deux approches complémentaires offrant la perspective de s’affranchir du traitement immunosuppresseur tout en protégeant les îlots de l’apoptose et de la perte de fonctionnalité du greffon induites par les mécanismes d’isolement, de culture et de transplantation : l’immunoisolation des îlots dans des capsules de biomatériaux et la co-transplantation avec des cellules souches mésenchymateuses (CSM).Au sein du projet européen de pancréas artificiel BIOCAPAN, nous avons évalué in vitro, la biocompatibilité de différents biomatériaux et mis en évidence un effet combiné de la présence de CSM et des tripeptides RGD sur le maintien de la viabilité et de la fonctionnalité des îlots encapsulés. L’évaluation ultérieure de la biocompatibilité et de l’effet ajouté de la capsule BIOCAPAN sur des animaux diabétiques permettra la validation de la capsule qui sera proposée à des tests d’essais cliniques.Nous avons également démontré, dans un modèle de co-culture d’îlots avec des CSM dans des conditions de culture classiques et exposées à des cytokines pro-inflammatoires, que les CSM régulaient les capacités sécrétrices des îlots probablement via la régulation de l’hème oxygénase 1 (HO-1). L’identification des facteurs de transcription régulant HO-1 ainsi que des médiateurs permettant la communication entre les deux types cellulaires sont des perspectives de développement.Ce travail a souligné l’intérêt, au sein d’une approche immuno-isolante, de la reconstitution d’un environnement favorable au sein de la capsule permettant la préservation de l’îlot notamment via l’utilisation de CSM. / Although, the metabolic results of islets transplantation for patient with type 1 diabetes are now well documented, they are counteracted by the adverse effects of immunosuppressive therapies and the long-term loss in graft functionality.During this thesis, we worked on two complementary approaches offering the perspective of avoiding immunosuppressive treatment while protecting islets from apoptosis and loss of functionality induced by the mechanisms of isolation, culture and transplantation. These two tools are islet immunoisolation in capsules composed of specific biomaterials and islets co-transplantation with mesenchymal stem cells (MSCs) described for their immunomodulatory, proangiogenic and cytoprotective properties.In the european project of bioartificial pancreas BIOCAPAN, we have evaluated in vitro the biocompatibility of several biomaterials and we have highlight a combined effect of the presence of MSCs and tripeptides RGD on the viability and the functionality maintenance of the encapsulated islets. Subsequent in vivo validation of the biocompatibility and the added effect of the BIOCAPAN capsule on diabetic animals will allow the final validation of the capsule to be proposed for clinical trials.We also demonstrated, in an islet co-culture model with MSCs under conventional culture conditions and exposed to pro-inflammatory cytokines, that MSCs regulate the secretory capacity of islets probably via the regulation of heme oxygenase 1 (HO-1) described for its antioxidant and anti-inflammatory properties. The identification of transcription factors regulating HO-1 as well as mediators, allowing communication between the two cell types, are development perspectives.This work underlined the interest, within an immuno-isolation approach, of the reconstitution of a favorable environment within the capsule allowing the preservation of islet physiology thanks to the use of MSCs.

Les matériaux poreux représentent une solution idéale en ingénierie tissulaire car leur structure peut offrir un environnement tridimensionnel aux cellules similaire à leur matrice extracellulaire tout en maintenant de bonnes propriétés mécaniques. Une première partie de cette thèse consiste à développer des matériaux poreux en polyuréthane (PU), dont l’architecture est contrôlée pour favoriser au mieux la survie et la croissance des cellules. Ces matériaux sont combinés à des traitements de surface (revêtement de polydopamine (PDA) et traitement plasma) pour augmenter notamment l’adhésion des cellules. Nous avons pu démontrer que le diamètre des interconnexions (i.e. l’ouverture connectant deux pores adjacents) impacte profondément la survie et l’organisation des cellules à long terme dans le matériau. Le revêtement de PDA s’est révélé efficace pour des cellules de type fibroblaste, alors que le traitement plasma favorise la colonisation des cellules souches mésenchymateuses (MSCs). Par ailleurs, nous avons étudié l’influence de la formulation du PU sur les capacités d’adhésion des cellules au matériau. Nous avons démontré que pour un ratio donné entre les réactifs, l’adhésion des cellules peut être exclue ou permise. Finalement, nous avons mis un gel de peptides auto-assemblés dans les pores du matériau pour fournir aux cellules un environnement similaire à leur matrice extracellulaire. Nous avons pu montrer que le gel permet d’augmenter la prolifération des MSCs. / Porous materials are an ideal solution in tissue engineering since they can provide a three-dimensional environment to the cells that is close to their extracellular matrix while keeping suitable mechanical properties. In the first part of this Thesis we develop porous materials made from polyurethane (PU) whose architecture is controlled to allow cells colonisation and growth. These materials are subsequently surface-treated (polydopamine (PDA) coating and plasma treatment) to enhance the adhesion of the cells. We were able to show that the interconnection diameter (i.e. the aperture connecting two adjacent pores) has an important impact on the long-term cell survival and organization in the material. Polydopamine coating was shown to be efficient for fibroblasts, whereas plasma treatment promoted mesenchymal stem cells (MSCs) colonisation. Besides, we also studied the influence of the PU formulation on the adhesion capacity of the cells. We demonstrated that at a given ratio between the reactants, cell adhesion could be allowed or prevented. Finally, we put a hydrogel of self-assembled peptides inside the pores of the material to provide an environment close to the extracellular matrix for the cells. We could show that the gel increases the proliferation ability of MSCs. In summary, this Thesis puts forward the important interplay between material properties and morphology of porous scaffolds.

Les champs électriques pulsés sont largement utilisés dans la recherche, la médecine, l'industrie alimentaire et d'autres procédés biotechnologiques. L'interaction d'une impulsion de 100 µs avec la membrane plasmique et la membrane du réticulum endoplasmique a été évaluée dans deux types cellulaires différents. La perméabilisation des organites cellulaires avec ce type d'impulsions est démontrée expérimentalement pour la première fois. L'utilisation d'une telle impulsion afin de contrôler les oscillations calciques spontanées dans les cellules souches mésenchymateuses humaines issues du tissu adipeux a été évaluée. En créant des pics calciques électro-induits d’amplitudes différentes, l'impulsion peut ou bien induire un pic calcique supplémentaire ou bien inhiber les oscillations spontanées pour quelques dizaines de minutes. Cette inhibition rend possible d’imposer à la cellule des pics d’amplitude et de fréquence désirés. Un essai d’application de l'impulsion 100 µs à des cellules souches subissant une différenciation osseuse a aussi été réalisé. Une impulsion électrique semble retarder la différenciation. Lors d'une différenciation osseuse, plusieurs couches cellulaires ont été observées. La caractérisation de ces couches a donné des résultats qui pourraient aider à obtenir des ostéoblastes matures dans un temps moindre que la normale. L'utilisation des champs électriques pulsés microsecondes, pour perméabiliser la membrane plasmique et les membranes internes des cellules, ainsi que pour moduler les concentrations du calcium intracellulaire, semble donc très intéressante pour étudier le rôle du calcium dans de nombreux processus physiologiques et pour manipuler les dynamiques calciques (oscillations, vagues, pics) dans différents types de cellules. Ainsi, cette technologie simple, facile à appliquer et disponible dans beaucoup de laboratoires serait envisageable pour la modulation et le contrôle de fonctions cellulaires basiques telles que la prolifération, la différenciation et l'apoptose. / Pulsed electric fields are widely used in research, medicine, food industry and other biotechnological processes. The interaction of one 100 µs pulse with the plasma membrane and the endoplasmic reticulum membrane was evaluated in two different cell types. Pulse amplitude ranged between 100 and 3 000 V/cm. Organelles membrane permeabilization using this kind of pulses was experimentally demonstrated for the first time. The use of such a pulse to control the spontaneous calcium oscillations in human-adipose mesenchymal stem cells was also assessed. By creating electro-induced calcium spikes of different amplitudes, the pulse can either add a supplementary spike, or, on the contrary, inhibit the spontaneous oscillations for some tens of minutes. During this inhibition period, the electric pulse-mediated addition of calcium spikes of desired amplitude and frequency is still possible. The delivery of 100 µs pulses to stem cells undergoing osteodifferentiation was also performed. The electric pulse seemed to delay the differentiation. Moreover, during osteogenic differentiation, cells cultures displayed an organization in a few cell layers. The characterization of these layers gave results that may help to obtain mature osteoblast in less time than usual one. The use of the microsecond electric pulses technology to permeabilize the plasma and the internal cell membranes as well as to modulate internal calcium concentrations is therefore interesting to study the role of calcium in many physiological processes and to manipulate the cell calcium dynamics (oscillations, waves, spikes) in different cell types. Doing so, this available, simple and easy to apply technology could be used for the modulation and the control of basic cellular functions such as proliferation, differentiation and apoptosis.

Le choc septique est actuellement la dixième cause de mortalité à travers le monde à égalité avec les infarctus du myocarde. Sa physiopathologie extrêmement complexe, entrelaçant un état pro-inflammatoire et anti-inflammatoire, rend caduque l’action des thérapeutiques conventionnelles. En ce sens, les recherches s’orientent vers les thérapeutiques innovantes et notamment les cellules souches/stromales mésenchymateuses (CSM). En effet, les études murines ont mis en évidence que les CSM étaient en mesure, notamment par leurs actions paracrines, d’améliorer la survie, la défaillance d’organes mais également la bactériémie de souris soumises à un choc septique. Cependant, les propriétés des CSM varient en fonction du tissu dont elles sont issues et particulièrement selon qu’elles proviennent de tissus fœtaux (cordon ombilical, placenta, liquide amniotique) ou adultes (moelle osseuse, tissu adipeux...). Ainsi, notre premier objectif a été de comparer, dans un modèle murin de choc septique, l’action des CSM issues de la moelle osseuse (MO) à celle des CSM issues de la gelée de Wharton (GW) du cordon ombilical. Cette étude murine a permis de mettre en évidence une action quelque peu différente, entre les CSM-GW et les CSM-MO, sur la physiopathologie du choc septique sans que pour autant, l’une des deux sources de CSM, ne se dégage significativement de l’autre en termes d’efficacité. Cependant, en raison de leur importante capacité de prolifération et de l’accessibilité du tissu source, les CSM-GW apparaissent comme étant nettement plus avantageuses que les CSM-MO. En conséquence, notre deuxième objectif a été d’évaluer l’action des CSM-GW dans un modèle porcin de péritonite afin de se rapprocher un peu plus près de la clinique humaine. Cette étude, menée en double aveugle et en présence continue d’un médecin réanimateur expérimenté, a permis de mettre en évidence que les CSM-GW, produites en grade clinique et utilisées juste après décongélation, étaient en mesure d’améliorer la survie, les paramètres hémodynamiques ainsi que les défaillances d’organes, selon un mécanisme d’action différent de celui rapporté par les études murines / Septic shock, equal to the myocardial infraction, is currently the tenth cause of death in the world. The pathophysiological complexity of this syndrome, with a simultaneous pro and anti- inflammatory state, results in the failure of conventional treatments. In this sense, research is focusing on innovative therapeutics agent, including mesenchymal stem cells (MSC). Indeed, murine studies of septic shock showed that MSC improve organ injuries, bacteremia and survival by notably a paracrine mechanism. However, MSC properties vary according to the source tissue, especially if they are derived from a fetal tissue (Wharton’s jelly (WJ), placenta amniotic fluid) or an adult tissue (bone marrow (BM), adipose tissue...). Our first objective was to compare, in a septic shock murine model, the effect of BM-MSC with that of WJ-MSC. Although some differences were observed, the same efficiency was demonstrated between these two sources. However, WJ-MSC present large advantages in comparison to BM-MSC due to their important proliferation capacities and potential quantities of umbilical cord donation. Consequently, our second objective was to investigate the effect of WJ-MSC administration in a relevant pig model of peritonitis in order to better mimic a clinical approach in humans. This study, conducted in double-blind and in presence of an experimented intensivist, showed that WJ-MSC produced in clinical grade and used immediately after thawing, improve survival, hemodynamic parameters and organ injuries by another action than that described in murine studies

L’ingénierie tissulaire osseuse a pour objectif de repousser les limitesexistantes de la régénération osseuse. Les stratégies proposées consistent àassocier à une matrice tridimensionnelle (3D) des cellules autologues, capables derégénérer en 3D un tissu fonctionnel. Le but de ce travail a été d’étudier l’importancede la communication cellulaire entre les cellules du compartiment stromal et lescellules endothéliales au sein d’une matrice tridimensionnelle poreuse constituée depolysaccharides naturels biodégradables. Nos résultats montrent que l’architecture etla nature de cette matrice permettent de guider la différenciation ostéoblastique descellules humaines mésenchymateuses issues de la moelle osseuse. L’organisationcellulaire en agrégats observée stimule les interactions cellulaires, et plusparticulièrement la formation de jonctions communicantes de type GAP et l’activitédes Connexines 43. Nous avons en également étudié la fonction des Pannexines 1et 3 dans la culture 3D. En conclusion, l’ensemble de nos travaux démontre que lesinteractions cellule-cellule constituent des événements majeurs dans cesmécanismes de régénération tissulaire. Les données cellulaires et expérimentalestémoignent de l’intérêt d’utiliser la totalité de la suspension de moelle osseuse pourfavoriser à la fois l’ostéoformation et la vascularisation du tissu. / Bone tissue engineering aims to resolve the existing limitations of boneregeneration methods. One of the proposed strategies consists on the association,within a three-dimensional (3D) matrix, with autologous cells able to regenerate afunctional 3D tissue. The purpose of this study was therefore to investigate theimpact of cellular communication, between cells of the stromal compartment andendothelial cells, within the three-dimensional porous matrix made of biodegradablenatural polysaccharides, focusing on bone repair. Our results show that thearchitecture and the nature of the 3D macroporous matrix promotes the guidance ofmesenchymal stems cells, derived from human bone marrow, towards theosteoblastic lineage. Also, that the organization in aggregates, promoted by the 3Dmatrices, stimulated cell communication, evidenced by the formation of GAPjunctions and activity of Connexins 43. We also focused on the function ofPannexines 1 and 3 for the 3D culture in these matrices of polysaccharides. Inconclusion, this work shows that cell-cell interactions play a major role in order toimprove bone tissue regeneration. Also, cellular and experimental data demonstratesthe advantage of using a total fraction of bone marrow cells to promote both boneformation and vascularization.